Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
16 July, 2018 02:15 IST
Alembic Pharma gets USFDA tentative approval for Ticagrelor Tablets
Source: IRIS | 12 Jul, 2018, 10.40AM
Comments  |  Post Comment

Alembic Pharmaceuticals today announced that the company has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ticagrelor Tablets, 90 mg.

The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Brilinta Tablets, 90 rng, of Astrazeneca Pharmaceuticals LP. Ticagrelor tablets are indicated to reduce the rate of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome (ACS) or a history of myocardial infarction (Ml).

Ticagrelor Tablets, 90 mg have an estimated market size of USD 625 million for twelve months ending December 2017 according to IQVIA.

Alembic now has a total of 75 ANDA approvals (65 final approvals and 10 tentative approvals) from USFDA.

Shares of the company gained Rs 5.75, or 1.08%, to trade at Rs 536.65. The total volume of shares traded was 678 at the BSE (10.27 a.m., Thursday).



Alembic Pharmaceuticals Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Infosys Q1 profit rises 4% y-o-y to Rs 36.12 bn - 13-Jul-2018 16:45
Fortis accepts Rs 40 bn investment offer from IHH Healthcare Berhad - 13-Jul-2018 10:38
White Organic Agro receives export order for 65 MT of cluster beans - 13-Jul-2018 09:51
Vakrangee partners with Reliance Nippon Life Asset Management - 13-Jul-2018 09:47
Larsen & Toubro wins orders worth Rs 30 bn - 13-Jul-2018 09:41
Cadila Healthcare's JV facility of Zydus Hopsira Oncology receives EIR from USFDA - 12-Jul-2018 13:23
Lupin receives nod for generic Nitrofurantoin capsules - 12-Jul-2018 12:39
Aban Offshore receives LoA for deployment of 3 jack-up rigs in UAE - 12-Jul-2018 12:26
Sun Pharma arm Dusa files lawsuit against Biofrontera - 12-Jul-2018 11:01
Larsen & Tubro wins orders worth Rs 23.88 bn - 12-Jul-2018 10:51
Alembic Pharma receives USFDA tentative approval for lloperidone Tablets - 12-Jul-2018 10:46
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer